{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:13:22Z","timestamp":1789668802749,"version":"4.0.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012117","name":"Lady Tata Memorial Trust","doi-asserted-by":"publisher","award":["01\/09\/2019"],"award-info":[{"award-number":["01\/09\/2019"]}],"id":[{"id":"10.13039\/100012117","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Department of Science and Technology- Fund for Improvement of Science and Technology Infrastructure in Universities and Higher Educational Institutions","award":["SR\/FST\/LSI-574\/2013"],"award-info":[{"award-number":["SR\/FST\/LSI-574\/2013"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The present study hypothesises that the selective brain \u03b22 receptor activation through \u03b22-adrenoreceptor agonist (\u03b22ARA), Formoterol (FMT), suppresses SNCA gene expression, a pathological hallmark of Parkinson\u2019s disease (PD) in brain. Further, it is also hypothesized that brain targeted delivery of Formoterol via polysorbate-80 surface modified solid lipid nanoparticles of Formoterol (FMT-SLNs-PS80) can improve its stability, therapeutic efficacy and avoid\/reduce peripheral off-target side effects. FMT-SLNs-PS80 was prepared by solvent injection method, the formulation was optimized by using Box\u2013Behnken design and characterized by measuring drug content, entrapment efficacy, particle size, zeta potentials and poly dispersibility. The FMT-SLNs-PS80, significantly decreases the SNCA expression, mitochondrial membrane damage and rotenone induced changes in oxidative (SOD, CAT, GSH and ROS) stress markers in SH-SY5Y cell lines. The ex vivo permeation study of the formulation using everted chicken ileum exhibited a steady state flux. The pharmacokinetic and tissue distribution studies of the formulation in rats showed a significant improvement in the kinetic parameters when compared to na\u00efve FMT, further the formulation also improved the brain bioavailability of FMT. The anti-Parkinson\u2019s efficacy studies of the formulation in mice showed a significant neuroprotection against rotenone-induced changes in behavioural and biochemical parameters. Further, the histopathological analysis of mice brain confirms a significant neuroprotective benefit. The present study successfully establishes the brain targeted delivery and anti-Parkinson\u2019s therapeutic efficacy of FMT-SLNs-PS80.<\/jats:p>","DOI":"10.1038\/s41598-023-46511-3","type":"journal-article","created":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T11:02:42Z","timestamp":1700046162000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Polysorbate 80 surface modified SLNs of formoterol suppress SNCA gene and mitochondrial oxidative stress in mice model of Parkinson\u2019s disease"],"prefix":"10.1038","volume":"13","author":[{"given":"Piyong","family":"Sola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kusuma Kumari","family":"Garikapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen Thaggikuppe","family":"Krishnamurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamta","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,15]]},"reference":[{"key":"46511_CR1","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1080\/17425247.2020.1779218","volume":"17","author":"P Sola","year":"2020","unstructured":"Sola, P., Krishnamurthy, P., Chintamaneni, P. K., Pindiprolu, S. K. S. & Kumari, M. Novel drug delivery systems of \u03b22 adrenoreceptor agonists to suppress SNCA gene expression and mitochondrial oxidative stress in Parkinson\u2019s disease management. Expert Opin. Drug Deliv. 17, 1119\u20131132 (2020).","journal-title":"Expert Opin. Drug Deliv."},{"key":"46511_CR2","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","volume":"124","author":"O-B Tysnes","year":"2017","unstructured":"Tysnes, O.-B. & Storstein, A. Epidemiology of Parkinson\u2019s disease. J. Neural Transm. 124, 901\u2013905 (2017).","journal-title":"J. Neural Transm."},{"key":"46511_CR3","first-page":"S79","volume-title":"Movement Disorders","author":"N Maserejian","year":"2020","unstructured":"Maserejian, N., Vinikoor-Imler, L. & Dilley, A. Movement Disorders S79\u2013S80 (Wiley, 2020)."},{"key":"46511_CR4","doi-asserted-by":"publisher","first-page":"743","DOI":"10.2147\/NDT.S2006","volume":"4","author":"J Jankovic","year":"2008","unstructured":"Jankovic, J. & Aguilar, L. G. Current approaches to the treatment of Parkinson\u2019s disease. Neuropsychiatr. Dis. Treat. 4, 743\u2013757 (2008).","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"46511_CR5","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1002\/ana.10513","volume":"53","author":"O Rascol","year":"2003","unstructured":"Rascol, O. et al. Limitations of current Parkinson\u2019s disease therapy. Ann. Neurol. 53, S3\u2013S15 (2003).","journal-title":"Ann. Neurol."},{"key":"46511_CR6","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1016\/0006-2952(89)90003-8","volume":"38","author":"DJ Edwards","year":"1989","unstructured":"Edwards, D. J., Sorisio, D. A. & Knopf, S. Effects of the \u03b22-adrenoceptor agonist clenbuterol on tyrosine and tryptophan in plasma and brain of the rat. Biochem. Pharmacol. 38, 2957\u20132965 (1989).","journal-title":"Biochem. Pharmacol."},{"key":"46511_CR7","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1212\/WNL.44.8.1491","volume":"44","author":"GM Alexander","year":"1994","unstructured":"Alexander, G. M., Schwartzman, R. J., Grothusen, J. R. & Gordon, S. W. Effect of plasma levels of large neutral amino acids and degree of parkinsonism on the blood-to-brain transport of levodopa in naive and MPTP parkinsonian monkeys. Neurology 44, 1491\u20131491 (1994).","journal-title":"Neurology"},{"key":"46511_CR8","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1126\/science.aaf3934","volume":"357","author":"S Mittal","year":"2017","unstructured":"Mittal, S. et al. \u03b22-Adrenoreceptor is a regulator of the \u03b1-synuclein gene driving risk of Parkinson\u2019s disease. Science 357, 891\u2013898 (2017).","journal-title":"Science"},{"key":"46511_CR9","doi-asserted-by":"publisher","first-page":"9336","DOI":"10.3390\/app11199336","volume":"11","author":"V Ravichandran","year":"2021","unstructured":"Ravichandran, V., Lee, M., Nguyen Cao, T. G. & Shim, M. S. Polysorbate-based drug formulations for brain-targeted drug delivery and anticancer therapy. Appl. Sci. 11, 9336 (2021).","journal-title":"Appl. Sci."},{"key":"46511_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2022.105380","volume":"158","author":"PT Krishnamurthy","year":"2022","unstructured":"Krishnamurthy, P. T., Kumari, M., Byran, G., Gangadharappa, H. V. & Garikapati, K. K. Neuroprotective approaches to halt Parkinson\u2019s disease progression. Neurochem. Int. 158, 105380 (2022).","journal-title":"Neurochem. Int."},{"key":"46511_CR11","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1111\/jphp.12815","volume":"69","author":"ME Ebada","year":"2017","unstructured":"Ebada, M. E. Drug repurposing may generate novel approaches to treating depression. J. Pharm. Pharmacol. 69, 1428\u20131436 (2017).","journal-title":"J. Pharm. Pharmacol."},{"key":"46511_CR12","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.addr.2007.04.011","volume":"59","author":"P Blasi","year":"2007","unstructured":"Blasi, P., Giovagnoli, S., Schoubben, A., Ricci, M. & Rossi, C. Solid lipid nanoparticles for targeted brain drug delivery. Adv. Drug Deliv. Rev. 59, 454\u2013477 (2007).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"46511_CR13","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1021\/nn304439f","volume":"7","author":"H Herd","year":"2013","unstructured":"Herd, H. et al. Nanoparticle geometry and surface orientation influence mode of cellular uptake. ACS Nano 7, 1961\u20131973 (2013).","journal-title":"ACS Nano"},{"key":"46511_CR14","doi-asserted-by":"publisher","first-page":"6655","DOI":"10.1021\/acsnano.5b01320","volume":"9","author":"M Yu","year":"2015","unstructured":"Yu, M. & Zheng, J. Clearance pathways and tumor targeting of imaging nanoparticles. ACS Nano 9, 6655\u20136674 (2015).","journal-title":"ACS Nano"},{"key":"46511_CR15","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/j.nano.2015.04.015","volume":"11","author":"DH Jo","year":"2015","unstructured":"Jo, D. H., Kim, J. H., Lee, T. G. & Kim, J. H. Size, surface charge, and shape determine therapeutic effects of nanoparticles on brain and retinal diseases. Nanomed. Nanotechnol. Biol. Med. 11, 1603\u20131611 (2015).","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"46511_CR16","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/smll.201101422","volume":"8","author":"D Bartczak","year":"2012","unstructured":"Bartczak, D. et al. Interactions of human endothelial cells with gold nanoparticles of different morphologies. Small 8, 122\u2013130 (2012).","journal-title":"Small"},{"key":"46511_CR17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","volume":"235","author":"C Saraiva","year":"2016","unstructured":"Saraiva, C. et al. Nanoparticle-mediated brain drug delivery: Overcoming blood\u2013brain barrier to treat neurodegenerative diseases. J. Control. Release 235, 34\u201347 (2016).","journal-title":"J. Control. Release"},{"key":"46511_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3109\/02652048.2012.692491","volume":"30","author":"J Kreuter","year":"2013","unstructured":"Kreuter, J. Mechanism of polymeric nanoparticle-based drug transport across the blood-brain barrier (BBB). J. Microencapsulation 30, 49\u201354 (2013).","journal-title":"J. Microencapsulation"},{"key":"46511_CR19","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jconrel.2011.08.017","volume":"161","author":"S Wohlfart","year":"2012","unstructured":"Wohlfart, S., Gelperina, S. & Kreuter, J. Transport of drugs across the blood\u2013brain barrier by nanoparticles. J. Control. Release 161, 264\u2013273 (2012).","journal-title":"J. Control. Release"},{"key":"46511_CR20","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1248\/cpb.59.260","volume":"59","author":"X-M Xu","year":"2011","unstructured":"Xu, X.-M. et al. Formulation and pharmacokinetic evaluation of tetracycline-loaded solid lipid nanoparticles for subcutaneous injection in mice. Chem. Pharm. Bull. 59, 260\u2013265 (2011).","journal-title":"Chem. Pharm. Bull."},{"key":"46511_CR21","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0168-3659(03)00330-4","volume":"92","author":"M Grassi","year":"2003","unstructured":"Grassi, M., Voinovich, D., Franceschinis, E., Perissutti, B. & Filipovic-Grcic, J. Theoretical and experimental study on theophylline release from stearic acid cylindrical delivery systems. J. Control. Release 92, 275\u2013289 (2003).","journal-title":"J. Control. Release"},{"key":"46511_CR22","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s40005-017-0320-1","volume":"47","author":"G-H Son","year":"2017","unstructured":"Son, G.-H., Lee, B.-J. & Cho, C.-W. Mechanisms of drug release from advanced drug formulations such as polymeric-based drug-delivery systems and lipid nanoparticles. J. Pharm. Investig. 47, 287\u2013296 (2017).","journal-title":"J. Pharm. Investig."},{"key":"46511_CR23","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3021738","volume":"2018","author":"WL Masiiwa","year":"2018","unstructured":"Masiiwa, W. L. & Gadaga, L. L. Intestinal permeability of artesunate-loaded solid lipid nanoparticles using the everted gut method. J. Drug Deliv. 2018, 3021738 (2018).","journal-title":"J. Drug Deliv."},{"key":"46511_CR24","first-page":"129","volume":"9","author":"WM Ibrahim","year":"2014","unstructured":"Ibrahim, W. M., AlOmrani, A. H. & Yassin, A. E. B. Novel sulpiride-loaded solid lipid nanoparticles with enhanced intestinal permeability. Int. J. Nanomed. 9, 129 (2014).","journal-title":"Int. J. Nanomed."},{"key":"46511_CR25","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jfda.2017.02.001","volume":"25","author":"C-H Lin","year":"2017","unstructured":"Lin, C.-H., Chen, C.-H., Lin, Z.-C. & Fang, J.-Y. Recent advances in oral delivery of drugs and bioactive natural products using solid lipid nanoparticles as the carriers. J. Food Drug Anal. 25, 219\u2013234 (2017).","journal-title":"J. Food Drug Anal."},{"key":"46511_CR26","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1590\/S1984-82502011000100012","volume":"50","author":"P Zakeri-Milani","year":"2014","unstructured":"Zakeri-Milani, P. et al. A study on enhanced intestinal permeability of clarithromycin nanoparticles. Braz. J. Pharm. Sci. 50, 121\u2013129 (2014).","journal-title":"Braz. J. Pharm. Sci."},{"key":"46511_CR27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0169-409X(00)00122-8","volume":"47","author":"J Kreuter","year":"2001","unstructured":"Kreuter, J. Nanoparticulate systems for brain delivery of drugs. Adv. Drug Deliv. Rev. 47, 65\u201381 (2001).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"46511_CR28","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/10611860290031877","volume":"10","author":"J Kreuter","year":"2002","unstructured":"Kreuter, J. et al. Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier. J. Drug Target. 10, 317\u2013325 (2002).","journal-title":"J. Drug Target."},{"key":"46511_CR29","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.2217\/nnm.14.165","volume":"10","author":"G da Rocha Lindner","year":"2015","unstructured":"da Rocha Lindner, G. et al. Improved neuroprotective effects of resveratrol-loaded polysorbate 80-coated poly (lactide) nanoparticles in MPTP-induced Parkinsonism. Nanomedicine 10, 1127\u20131138 (2015).","journal-title":"Nanomedicine"},{"key":"46511_CR30","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/10611860500071292","volume":"13","author":"TM G\u00f6ppert","year":"2005","unstructured":"G\u00f6ppert, T. M. & M\u00fcller, R. H. Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: Comparison of plasma protein adsorption patterns. J. Drug Target. 13, 179\u2013187 (2005).","journal-title":"J. Drug Target."},{"key":"46511_CR31","first-page":"85","volume-title":"International Congress Series","author":"J Kreuter","year":"2007","unstructured":"Kreuter, J. International Congress Series 85\u201394 (Elsevier, 2007)."},{"key":"46511_CR32","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1080\/03639045.2017.1405977","volume":"44","author":"TA Ahmed","year":"2018","unstructured":"Ahmed, T. A., El-Say, K. M., Hosny, K. M. & Aljaeid, B. M. Development of optimized self-nanoemulsifying lyophilized tablets (SNELTs) to improve finasteride clinical pharmacokinetic behavior. Drug Dev. Ind. Pharm. 44, 652\u2013661 (2018).","journal-title":"Drug Dev. Ind. Pharm."},{"key":"46511_CR33","doi-asserted-by":"publisher","first-page":"474","DOI":"10.3109\/21691401.2016.1173046","volume":"45","author":"SV Talluri","year":"2017","unstructured":"Talluri, S. V. et al. Application of quality-by-design approach to optimize diallyl disulfide-loaded solid lipid nanoparticles. Artif. Cells Nanomed. Biotechnol. 45, 474\u2013488 (2017).","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"46511_CR34","first-page":"17","volume":"10","author":"J Emami","year":"2015","unstructured":"Emami, J., Mohiti, H., Hamishehkar, H. & Varshosaz, J. Formulation and optimization of solid lipid nanoparticle formulation for pulmonary delivery of budesonide using Taguchi and Box\u2013Behnken design. Res. Pharm. Sci. 10, 17 (2015).","journal-title":"Res. Pharm. Sci."},{"key":"46511_CR35","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3390\/pharmaceutics12050448","volume":"12","author":"N Dudhipala","year":"2020","unstructured":"Dudhipala, N. & Gorre, T. Neuroprotective effect of ropinirole lipid nanoparticles enriched hydrogel for Parkinson\u2019s disease: In vitro, ex vivo, pharmacokinetic and pharmacodynamic evaluation. Pharmaceutics 12, 448 (2020).","journal-title":"Pharmaceutics"},{"key":"46511_CR36","first-page":"1","volume":"6","author":"R Jain","year":"2015","unstructured":"Jain, R., Sukla, S. K., Nema, N. & Panday, A. Drug nano-particle: A release kinetics. J. Nanomed. Nanotechnol. 6, 1 (2015).","journal-title":"J. Nanomed. Nanotechnol."},{"key":"46511_CR37","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ijbiomac.2017.05.015","volume":"103","author":"K Soni","year":"2017","unstructured":"Soni, K., Mujtaba, A. & Kohli, K. Lipid drug conjugate nanoparticle as a potential nanocarrier for the oral delivery of pemetrexed diacid: Formulation design, characterization, ex vivo, and in vivo assessment. Int. J. Biol. Macromol. 103, 139\u2013151 (2017).","journal-title":"Int. J. Biol. Macromol."},{"key":"46511_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5152\/TJAR.2016.02438","volume":"44","author":"A\u00dc D\u00fczl\u00fc","year":"2016","unstructured":"D\u00fczl\u00fc, A. \u00dc., G\u00fcnayd\u0131n, B., \u015e\u00fck\u00fcro\u011flu, M. K. & De\u011fim, \u0130T. Release pattern of liposomal bupivacaine in artificial cerebrospinal fluid. Turk. J. Anaesthesiol. Reanim. 44, 1 (2016).","journal-title":"Turk. J. Anaesthesiol. Reanim."},{"key":"46511_CR39","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.1007\/s11033-014-3216-4","volume":"41","author":"E Rostami","year":"2014","unstructured":"Rostami, E., Kashanian, S. & Azandaryani, A. Preparation of solid lipid nanoparticles as drug carriers for levothyroxine sodium with in vitro drug delivery kinetic characterization. Mol. Biol. Rep. 41, 3521\u20133527 (2014).","journal-title":"Mol. Biol. Rep."},{"key":"46511_CR40","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1113\/jphysiol.1954.sp005036","volume":"123","author":"TH Wilson","year":"1954","unstructured":"Wilson, T. H. & Wiseman, G. The use of sacs of everted small intestine for the study of the transference of substances from the mucosal to the serosal surface. J. Physiol. 123, 116 (1954).","journal-title":"J. Physiol."},{"key":"46511_CR41","doi-asserted-by":"publisher","DOI":"10.1088\/0957-4484\/24\/41\/415102","volume":"24","author":"YR Neupane","year":"2013","unstructured":"Neupane, Y. R., Sabir, M., Ahmad, N., Ali, M. & Kohli, K. Lipid drug conjugate nanoparticle as a novel lipid nanocarrier for the oral delivery of decitabine: Ex vivo gut permeation studies. Nanotechnology 24, 415102 (2013).","journal-title":"Nanotechnology"},{"key":"46511_CR42","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1152\/advan.00017.2013","volume":"37","author":"KL Hamilton","year":"2013","unstructured":"Hamilton, K. L. & Butt, A. G. Glucose transport into everted sacs of the small intestine of mice. Adv. Physiol. Educ. 37, 415\u2013426 (2013).","journal-title":"Adv. Physiol. Educ."},{"key":"46511_CR43","first-page":"9436106","volume":"2016","author":"JO Bhangale","year":"2016","unstructured":"Bhangale, J. O. & Acharya, S. R. Anti-Parkinson activity of petroleum ether extract of Ficus religiosa (L.) leaves. Adv. Pharmacol. Sci. 2016, 9436106 (2016).","journal-title":"Adv. Pharmacol. Sci."},{"key":"46511_CR44","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.bbadis.2006.01.008","volume":"1762","author":"G Casadesus","year":"2006","unstructured":"Casadesus, G. et al. Luteinizing hormone modulates cognition and amyloid-\u03b2 deposition in Alzheimer APP transgenic mice. Biochim. Biophys. Acta (BBA) Mol. Basis Dis. 1762, 447\u2013452 (2006).","journal-title":"Biochim. Biophys. Acta (BBA) Mol. Basis Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46511-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46511-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46511-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T11:09:06Z","timestamp":1700046546000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46511-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,15]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["46511"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-46511-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,15]]},"assertion":[{"value":"11 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19942"}}